Literature DB >> 1615671

Autoimmune disease and the nervous system.

L Steinman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1615671      PMCID： PMC1003370     

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  13 in total

1.  Mononuclear cell analysis of muscle biopsies in prednisone-treated and untreated Duchenne muscular dystrophy. CIDD Study Group.

Authors:  J T Kissel; K L Burrow; K W Rammohan; J R Mendell
Journal:  Neurology       Date:  1991-05       Impact factor: 9.910

Review 2.  Prospects for specific immunotherapy in myasthenia gravis.

Authors:  L Steinman; R Mantegazza
Journal:  FASEB J       Date:  1990-07       Impact factor: 5.191

3.  Thymus in myasthenia gravis. Isolation of T-lymphocyte lines specific for the nicotinic acetylcholine receptor from thymuses of myasthenic patients.

Authors:  A Melms; B C Schalke; T Kirchner; H K Müller-Hermelink; E Albert; H Wekerle
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

4.  A population-based study of multiple sclerosis in twins.

Authors:  G C Ebers; D E Bulman; A D Sadovnick; D W Paty; S Warren; W Hader; T J Murray; T P Seland; P Duquette; T Grey
Journal:  N Engl J Med       Date:  1986-12-25       Impact factor: 91.245

5.  Shared human T cell receptor V beta usage to immunodominant regions of myelin basic protein.

Authors:  K W Wucherpfennig; K Ota; N Endo; J G Seidman; A Rosenzweig; H L Weiner; D A Hafler
Journal:  Science       Date:  1990-05-25       Impact factor: 47.728

6.  Thymectomy for myasthenia gravis: recent observations and comparisons with past experience.

Authors:  D G Mulder; M Graves; C Herrmann
Journal:  Ann Thorac Surg       Date:  1989-10       Impact factor: 4.330

7.  Molecular mimicry and myasthenia gravis. An autoantigenic site of the acetylcholine receptor alpha-subunit that has biologic activity and reacts immunochemically with herpes simplex virus.

Authors:  P L Schwimmbeck; T Dyrberg; D B Drachman; M B Oldstone
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

8.  Modulation of MHC class II antigen expression in human myoblasts after treatment with IFN-gamma.

Authors:  R Mantegazza; S M Hughes; D Mitchell; M Travis; H M Blau; L Steinman
Journal:  Neurology       Date:  1991-07       Impact factor: 9.910

9.  A pilot trial of Cop 1 in exacerbating-remitting multiple sclerosis.

Authors:  M B Bornstein; A Miller; S Slagle; M Weitzman; H Crystal; E Drexler; M Keilson; A Merriam; S Wassertheil-Smoller; V Spada
Journal:  N Engl J Med       Date:  1987-08-13       Impact factor: 91.245

10.  A juxta-membrane epitope on the human acetylcholine receptor recognized by T cells in myasthenia gravis.

Authors:  G C Harcourt; N Sommer; J Rothbard; H N Willcox; J Newsom-Davis
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.